We are entering a new era of immunological science, where the therapeutic potential of the immune system to ensure human health and well-being has never been more glorious. 
 
New advances in our understanding of how immune and inflammatory responses are regulated helped slow a pandemic in a record time and save millions of lives and are changing the outcome of major human diseases. Bolstered by progress made in technology, data and computational science, and gene and cell engineering, the list of diseases benefiting from immunotherapies continues to grow. Enormous successes with immunotherapy have been achieved in infectious diseases, cancer, autoimmunity and allergy, inflammatory and metabolic diseases, and hopefully will soon transform how we tackle neurodegenerative diseases, atherosclerosis, and even ageing.
 
The immunotherapy revolution proceeds onward and the need for training new immunologists has never been more pressing. Medical and research centres are opening up immunology faculty positions across the academic rank throughout the globe. Pharmaceutical companies, biotechnology enterprises, and investment firms are all looking for highly skilled immunologists that can join them in the immunotherapy race.
 
And we immunologists need to ensure that immunology research continue to grow. We need to face the increasing demand for immunologists by building more educational opportunities, by taking advantage of the progress in virtual teaching platforms to enhance immunology outreach, and by encouraging the younger generations to join the field.
 
This is why it has never been more timely to organise the 2023 Immunology Congress In Cape Town, South Africa. The meeting will bring together more than 5,000 immunologists from 70 countries during 5 days of scientific exchange. We will have 500 oral presentations, 2,300 Posters and 4,000 abstracts. The meeting will include Keynotes, Plenaries, and Scientific Symposia given by established immunologists but also rising stars and trainees. We will also host debates and round-table discussions on global health, equitable science, data sharing, misinformation, education and outreach, pandemic preparedness, the future of funding and publishing, and many, many more topics.
 
This gathering of immunologists will be a landmark occasion. It will be the first time that the immunology congress will be held in Africa, and it is also the first congress of the global immunology community after the start of the COVID-19 pandemic. It will provide unique opportunities to share new knowledge in many areas of immunological research, to discuss state of the art immunotherapy strategies, and to imagine a vibrant future of immunology research that contributes to the treatment of most human diseases.
 
Information about Session Formats, Topics and already confirmed speakers to date can be found here.

We hope that you will be able to join IUIS 2023 Congress and help make it the most vibrant immunology gathering to date that takes the measure of recent achievements in immunological science and how much promise immunology still holds for the future of medicine.
 

The IUIS Constitution requires elections for governance every three years; therefore, the 2022 elections will go ahead in the absence of an in-person General Assembly, as approved by the IUIS Council.

The triennial IUIS Executive Committee and Council Elections will take place virtually from 1-15 October 2022, prior to the 18th Virtual IUIS General Assembly on Sunday, 20 November 2022. Valued members of the IUIS have, in the past months, sent in their nominations and endorsements for the following seats:
 

The IUIS 2022-2025 Election of officers will be conducted through the online voting tool, ElectionBuddy between 1-15 October 2022. Those eligible to vote in the elections are the confirmed delegates to the 18th Virtual IUIS General Assembly. Information about the candidates is available on a password-protected webpage with access reserved for candidates and voters. 

The results of the IUIS Governance elections will be announced at the 18th Virtual IUIS General Assembly which will be held virtually via Zoom on Sunday, 20 November 2022 from 13:00-15:00 CET. The meeting is open to invited participants only. The results of the elections will be made public on IUIS shortly after the 18th Virtual IUIS General Assembly.

New EFIS report on European COVID-19 vaccination strategies.

The European Federation of Immunological Societies (EFIS) has published a new expert report called ‘Lessons learned from European COVID-19 vaccination rollout programmes’ which features case studies of vaccination strategies across Europe in response to the COVID-19 pandemic. The report examines different steps taken to encourage vaccination uptake in a range of countries and important lessons we can incorporate to strengthen international preparedness for future pandemics and advance global health. Read more and download the report here.

Upcoming EFIS Strategic Retreat

When in 2019 the EFIS strategic retreat was held in Berlin, it was the first time that representatives from EFIS-national societies had been brought together to specifically discuss how EFIS could better meet the needs of the European immunology community. One of the major achievements of the Berlin meeting was the formation of three new EFIS Task Forces on diversity, education, and vaccines – which remain of central importance to the EFIS Board.

Given the continued need for dialogue with societies on issues such as these, together with the unprecedented events of the last three years, EFIS President Federica Sallusto has again invited delegates from EFIS national societies, partners, study groups and task forces to participate in the 2022 EFIS retreat to be held this November in Stresa, Italy for another opportunity to proactively discuss and engage on the future direction of EFIS.

Deadlines for EFIS support

Please note that the next deadline for EFIS-EJI Meeting Support and EFIS – IL short-term fellowships is 4 November 2022. To keep up to date with all EFIS news, sign up for their NewsFlash and connect with them on Twitter, Facebook or LinkedIn.

Immunopaedia.org.za is the official educational provider of pre-course and online IUIS immunology courses, where we have supported courses in south, west, north, and east Africa, Latin America, India, and Iran. Immunopaedia is open-access and delivers current educational content to provide frameworks of knowledge to IUIS course participants before they embark on face-to-face courses.

Learn with free online courses (more info) or through our real-life case studies with immunology explanations and quizzes. Immunopaedia provides summaries of the latest research on SARS-CoV-2 and other immunology topics (Read Summaries).

Immunopaedia, in collaboration with the IUIS and Frontiers in Immunology, has organised a webinar series on various immunology topics (Read our summaries of the webinars).

You can also “meet” prominent immunologists from across the globe, either in written or video interviews or get to know our network of early-career immunologists through our Immunopaedia Ambassadors Programme. 

Please use:

• this form to share your society’s achievements or any other news on our website or social media profiles and
• this form for all non-IUIS related meetings you would like to advertise. 

Please use this form to submit a career opportunity.

Copyright © 2022 IUIS, All rights reserved.
You are receiving this email because you are a member of an IUIS member society or have registered interest in receiving IUIS updates.

Address
IUIS Central Office
c/o K.I.T. Group GmbH
Kurfürstendamm 71
10709 Berlin, Germany

info@iuis.org | www.iuis.org
Tel.: +49 30 246 03-0 | Fax: +49 30 246 03-200

Legal Notice    Private Policy

Wish to change how you receive these emails?
You can update your preferences or unsubscribe from this list.